JPMorgan upgrades Gilead and Pfizer, sees upside potential in healthcare sector
From Nasdaq: 2025-04-01 08:15:00 Wall Street analysts recently upgraded Gilead Sciences Inc. (NASDAQ: GILD), signaling renewed confidence in the healthcare
Category: Earnings
Mainz Biomed N.V. saw revenue increase, operating loss decrease, and net loss decrease in 2024.
From GlobeNewswire: 2025-04-01 08:01:00 Mainz Biomed N.V. reported a 33% increase in lab network revenue year over year, driven by
Gold and silver mining ETFs performing well in 2025 with potential for further growth
From Nasdaq: 2025-04-01 08:00:00 Several gold and silver mining ETFs are outperforming the market in 2025. Gold prices have surged
Paychex and Cintas report strong earnings, labor market robust, Paychex acquires Paycor.
From Nasdaq: 2025-04-01 07:45:00 Paychex Inc. (NASDAQ: PAYX) and Cintas Corp. (NASDAQ: CTAS) both reported strong earnings, indicating a robust
Trust Stamp reported strong revenue growth for Q4 2024 and anticipates further revenue increase in 2025.
From GlobeNewswire: 2025-04-01 07:00:00 Trust Stamp filed its 10-K report for the 2024 Financial Year, reporting Q4 2024 Revenue of
AmpliTech reports FY 2024 financial results with total revenue of $10.25 million and $11 million net loss due to fraud
From GlobeNewswire: 2025-04-01 07:00:00 AmpliTech Group, Inc. (Nasdaq: AMPG) reported FY 2024 financial results, including $10.25 million in total revenue
PyroGenesis reports strong financials, revenue growth, operational milestones, and contract wins
From GlobeNewswire: 2025-03-31 22:49:00 PyroGenesis Inc. reported a quarterly revenue of $4.22 million, up 40% year-over-year, with a quarterly net
Firm Capital Property Trust reports strong Q4/2024 results, showing financial stability and growth.
From GlobeNewswire: 2025-03-31 21:16:00 Firm Capital Property Trust (FCPT) reports strong financial results for Q4/2024, with an increase in Adjusted
Enthusiast Gaming saw improvement in financials in Q4 and 2024, focusing on high-margin growth.
From GlobeNewswire: 2025-03-31 16:30:00 Enthusiast Gaming Holdings Inc. reported a Quarterly Adjusted EBITDA of $1.9 million in Q4, marking a
FibroBiologics reports increased research expenses, reduced net loss, and focus on clinical programs.
From GlobeNewswire: 2025-03-31 16:25:00 FibroBiologics completes master cell bank for CYWC628 product candidate after safety testing. Phase 1/2 trial for
Helport AI reports revenue growth in first half of fiscal year 2025
From GlobeNewswire: 2025-03-31 16:01:00 In the first half of fiscal year 2025, Helport AI reported a 13.1% revenue increase to
Evaxion Biotech is expected to report a significant decrease in EPS for Q4 2024.
From Nasdaq Inc.: 2025-03-31 16:00:00 Evaxion Biotech A/S (EVAX) is set to report earnings on 04/01/2025 for the quarter ending
Multiple companies reporting after-hours earnings on 03/31/2025, with mixed forecasts for earnings per share.
From Nasdaq: 2025-03-31 14:00:00 Several companies are set to report earnings after hours on 03/31/2025. Progress Software Corporation (PRGS) is
Tesla receives permit for robotaxi service in California, Lyft plans driverless ride-hailing service
From Nasdaq.: 2025-03-31 11:03:00 In recent news, Tesla received a permit from California to operate its robotaxi service, marking a
Meta's Advantage+ Shopping tool driving significant revenue growth and advertising success for the company.
From Nasdaq: 2025-03-31 11:03:00 Meta Platforms (NASDAQ: META) has seen significant success with Advantage+ Shopping, a key growth driver for
Kartoon Studios reports strong financial results and continues to see growth in viewers and revenue.
From GlobeNewswire: 2025-03-31 09:10:00 Kartoon Studios reported a decrease of 57.4% in operating expenses in 2024, with an improved operating
Traws Pharma presents positive data for tivoxavir marboxil against bird flu and COVID-19
From GlobeNewswire: 2025-03-31 09:00:00 Traws Pharma’s tivoxavir marboxil shows significant antiviral activity in animal models and positive Phase 1 data
Connect Biopharma appoints new leadership and unveils rapid clinical program with positive financial results.
From GlobeNewswire: 2025-03-31 09:00:00 Connect Biopharma announced key leadership appointments, with Barry Quart, Pharm.D. as CEO and David Szekeres as
Reading International, Inc. reports strong fourth quarter results, but full year impacted by industry changes.
From GlobeNewswire: 2025-03-31 09:00:00 Reading International, Inc. announced its financial results for the fourth quarter and full year of 2024.
Data Storage Corp. (DTST) reports positive 2024 fiscal year results with increased revenue and net income.
From GlobeNewswire: 2025-03-31 08:30:00 Data Storage Corporation (DTST) expanded CloudFirst platform in 2024 with 4 new Tier III data centers
Opus Genetics reports strong financial results, progresses with gene therapy candidates
From GlobeNewswire: 2025-03-31 08:20:00 Opus Genetics, Inc. reports strong financial results with a $21.5 million financing boost to supplement a
Synergy CHC Corp reports decrease in revenue but remains profitable, focusing on growth in 2025.
From GlobeNewswire: 2025-03-31 08:00:00 Synergy CHC Corp. announced its financial results for the fourth quarter and full year 2024, with
Monopar reports financial results, raises funds, and advances clinical programs
From GlobeNewswire: 2025-03-31 08:00:00 Monopar Therapeutics Inc. announced their fourth quarter and full-year 2024 financial results, highlighting the in-licensing of
Concerns over tariffs impacting American stock markets, analyst-favorite low P/E consumer cyclical stocks are buys
From Nasdaq.: 2025-03-31 07:45:00 Concerns over tariffs are impacting American stock markets, with the S&P 500 down 2% in 2025.
SAB BIO reports positive financial results for Q4 2024 and plans to advance SAB-142 development
From GlobeNewswire: 2025-03-31 07:32:00 SAB BIO reported financial results for Q4 2024 and the full fiscal year, highlighting progress in